Deguelin Attenuates Non-Small-Cell Lung Cancer Cell Metastasis by Upregulating PTEN/KLF4/EMT Signaling Pathway
Related Experiment Video
Updated: Sep 21, 2025
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Guohua Lu1, Yinan Yao1, Xiaochen Zhang2
1Department of Respiratory Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
Abstract:
Non-small-cell lung cancer (NSCLC) is the most common lung cancer and a major cause of cancer mortality worldwide. Deguelin plays a vital inhibitory role in NSCLC initiation and development. However, the downstream mechanism of deguelin-suppressed metastasis of NSCLC cells is still not completely understood. Interestingly, phosphatase and tensin homologue deleted on chromosome 10 (PTEN) and Krüppel-like factor 4 (KLF4) also contribute to inhibition of metastasis in NSCLC cells. Here, we demonstrated that deguelin significantly upregulated PTEN and KLF4 expressions and PTEN positively upregulated KLF4 expression in NSCLC cells including A549 and PC9 cells. Moreover, overexpressions of PTEN and KLF4 inhibited the migration and invasion of NSCLC cells, an effect similar to that of deguelin. Furthermore, overexpressions of PTEN and KLF4 could suppress the epithelial-mesenchymal transition (EMT), an effect also similar to that of deguelin. Additionally, deguelin displayed a significant antitumor ability by upregulating PTEN and KLF4 expressions in mice model with NSCLC cells. Together, these results indicated that deguelin could be a potential therapeutic agent through upregulating PTEN and KLF4 expressions for NSCLC therapy.
Insights
Deguelin inhibits non-small-cell lung cancer (NSCLC) metastasis by increasing PTEN and KLF4. This natural compound shows potential as a therapeutic agent for NSCLC, suppressing tumor growth and spread.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Non-small-cell lung cancer (NSCLC) is a leading cause of cancer mortality globally.
- Deguelin is known to inhibit NSCLC initiation and development, but its downstream mechanisms are not fully understood.
- Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) and Krüppel-like factor 4 (KLF4) are implicated in inhibiting NSCLC metastasis.
Purpose of the Study:
- To elucidate the downstream mechanism by which deguelin suppresses NSCLC metastasis.
- To investigate the roles of PTEN and KLF4 in deguelin-mediated inhibition of NSCLC.
- To evaluate the therapeutic potential of deguelin in an NSCLC mice model.
Main Methods:
- Investigated the effect of deguelin on PTEN and KLF4 expression in NSCLC cell lines (A549, PC9).
- Examined the regulatory relationship between PTEN and KLF4 expression.
- Assessed the impact of PTEN and KLF4 overexpression on NSCLC cell migration, invasion, and epithelial-mesenchymal transition (EMT).
- Evaluated deguelin's antitumor activity in a mice model by measuring PTEN and KLF4 upregulation.
Main Results:
- Deguelin significantly upregulated PTEN and KLF4 expression in NSCLC cells.
- PTEN was found to positively regulate KLF4 expression.
- Overexpression of PTEN and KLF4 inhibited NSCLC cell migration, invasion, and EMT, mimicking deguelin's effects.
- Deguelin demonstrated significant antitumor effects in vivo by upregulating PTEN and KLF4.
Conclusions:
- Deguelin suppresses NSCLC metastasis by upregulating PTEN and KLF4.
- PTEN positively regulates KLF4, contributing to deguelin's inhibitory effects.
- Deguelin holds promise as a potential therapeutic agent for NSCLC by modulating the PTEN/KLF4 pathway.
